67040-04-4

Upstream product

• 67039-99-0 3-[(1R,2R,3R,5S)-2-[(E)-4-Phenoxy-3-(tetrahydro-pyran-2-yloxy)-but-1-enyl]-3,5-bis-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-2-phenylselanyl-propionic acid methyl ester 
• 67040-00-0 (E)-3-[(1R,2R,3R,5S)-2-[(E)-4-Phenoxy-3-(tetrahydro-pyran-2-yloxy)-but-1-enyl]-3,5-bis-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-acrylic acid methyl ester 
• 67039-98-9 3-[(1R,2R,3R,5S)-2-[(E)-4-Phenoxy-3-(tetrahydro-pyran-2-yloxy)-but-1-enyl]-3,5-bis-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-propionic acid methyl ester 
• 67040-02-2 (E)-3-[(1R,2R,3R,5S)-2-[(E)-4-Phenoxy-3-(tetrahydro-pyran-2-yloxy)-but-1-enyl]-3,5-bis-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-propenal 
• 67040-01-1 (E)-3-[(1R,2R,3R,5S)-2-[(E)-4-Phenoxy-3-(tetrahydro-pyran-2-yloxy)-but-1-enyl]-3,5-bis-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-prop-2-en-1-ol 
• 65469-90-1 (1S,2R,3R,4R)-2-((E)-3-Methoxy-allyl)-3-[(E)-4-phenoxy-3-(tetrahydro-pyran-2-yloxy)-but-1-enyl]-4-(tetrahydro-pyran-2-yloxy)-cyclopentanol 
• 40667-55-8 2-oxa-6-syn-<3αβ-(tetrahydropyran-2-yloxy)-4-phenoxy-1-trans-butenyl>-7-anti-(tetrahydropyran-2-yloxy)-cis-bicyclo<3.3.0>octan-3-ol 
• 67039-97-8 3-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-3-hydroxy-4-phenoxy-but-1-enyl)-cyclopentyl]-propionic acid methyl ester 
• 65469-92-3 (4aR,5R,6R,7aS)-5-((E)-3-Hydroxy-4-phenoxy-but-1-enyl)-octahydro-cyclopenta[b]pyran-2,6-diol 
• 67040-03-3 (2E,4E,6E)-7-[(1R,2R,3R,5S)-2-[(E)-4-Phenoxy-3-(tetrahydro-pyran-2-yloxy)-but-1-enyl]-3,5-bis-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-hepta-2,4,6-trienoic acid methyl ester 

Relevant academic research and scientific papers

Prostaglandin Analogues Possessing Antinidatory Effects. 2. Modification of the α Chain

Additional double bonds were introduced into the α chain in 16-phenoxy-, 16-(3-chlorophenoxy)-, 16--, and 16-(4-chlorophenoxy)-17,18,19,20-tetranorprostaglandins which have antinidatory effects.Of these analogues, the Δ3/